Abstract:

In order to investigate the international competitive ability of China in transgenic technology research and development, this paper searched  SCI articles related to transgenic technology from 1973-2014, authorized genetically modified patents and GM events approved for commercial production throughout databases like Web of Science, Derwent and ISAAA research report. Through analysis based on fundamental and development research, the results indicated that the SCI papers published by Chinese researchers were ranked the third place, while the SCI papers on transgenic rice and cotton were ranked the first place in the world. Meanwhile, the authorized genetically modified patents in China were ranked the second place, only behind the USA. While the number of authorized genetically modified patents in China were nearly doubled that of Japan, which took the third place in the world. Differ from the other countries, where the transgenic technology is usually provided by big multinational companies, transgenic technology in China almost comes from government research institutions within China at present.

Key words: transgenic technology, research and development, patent, competitive ability

摘要：

为研究中国转基因技术研发的国际竞争力,以Web of Science、德温特专利数据库（DII）和ISAAA系列研究报告等数据库和文献为统计源,查询1973-2014年间所发表的转基因SCI论文、所授权的转基因专利和批准商业化种植的转基因转化事件。基于基础研究和开发研究分析得出如下结果：中国研究人员所发表的SCI论文处于国际第三位,其中转基因水稻和转基因棉花SCI论文处于国际第一位；授权的转基因专利仅次于美国而处于国际第二位,授权专利数几乎是处于第三位日本的两倍；与其他种植转基因国家所采用的技术绝大多数来自跨国公司不同,中国目前种植的转基因作物技术几乎全部来自国内政府研究机构或企业。

关键词: 转基因技术, 研发, 专利, 竞争力